Literature DB >> 9603695

Diet and cardiovascular disease prevention: what works?

L Van Horn1, R E Kavey.   

Abstract

Diet is routinely recommended as the primary strategy for the prevention and treatment of high blood cholesterol. The National Cholesterol Education Program (NCEP), the American Heart Association (AHA), and a host of other health and medical organizations have advocated a diet low in total and saturated fat and cholesterol for reducing risk of cardiovascular disease. What is the evidence supporting these guidelines and the expected efficacy of dietary treatment? There is growing awareness that despite well-documented rationale for the dietary approach, many eligible patients are not routinely prescribed dietary treatment, and among those who are, there is limited response. What are the obstacles in implementing effective dietary intervention for prevention of cardiovascular disease? What are both the theoretical and practical limitations to achieving long-term adherence to diet and what strategies have been shown to be most effective? A review of the data surrounding these diet-lipid relationships is presented along with recently tested and promising behavioral approaches to facilitating patient adherence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9603695     DOI: 10.1007/BF02892285

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  2 in total

1.  Poly is more effective than monounsaturated fat for dietary management in the metabolic syndrome: The muffin study.

Authors:  Michael Miller; John D Sorkin; Laura Mastella; Aimee Sutherland; Jeffrey Rhyne; Patrick Donnelly; Kathy Simpson; Andrew P Goldberg
Journal:  J Clin Lipidol       Date:  2016-05-06       Impact factor: 4.766

2.  Make Better Choices (MBC): study design of a randomized controlled trial testing optimal technology-supported change in multiple diet and physical activity risk behaviors.

Authors:  Bonnie Spring; Kristin Schneider; H G McFadden; Jocelyn Vaughn; Andrea T Kozak; Malaina Smith; Arlen C Moller; Leonard Epstein; Stephanie W Russell; Andrew DeMott; Donald Hedeker
Journal:  BMC Public Health       Date:  2010-09-29       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.